Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 8Depression 8Anxiety Disorders 7Neoplasm Metastasis 3Melanoma 2Depressive Disorder, Major 2Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Opioid-Related Disorders 1Lymphoma 1Hospice 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Endocrine Gland Neoplasms 1Depressive Disorder 1Caregiver Distress 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1Agnosia 1

Interventions

Interviews as Topic 12Specimen Handling 9Practice Guidelines as Topic 8Standard of Care 7Educational Status 7Methods 5Early Intervention, Educational 5Patient Navigation 4Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Resistance Training 1Psychotherapy 1Psilocybin 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hematopoietic and Lymphatic System Neoplasm × Psilocybin × Clear all
NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Roswell Park Cancer Institute

Phase 2 Not yet recruiting
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡